Showing results (171-180 of 561) with videos related to
Sort By:
Pageof 57
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2003
Central muscarinic acetylcholine receptor availability in patients treated with clozapineThomas J Raedler, Michael B Knable, Douglas W Jones, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 17, 2014
Effects of neuregulin 3 genotype on human prefrontal cortex physiologyHeike Tost, Joseph H Callicott, Roberta Rasetti, et al.Schizophrenia Research|June 16, 2007
Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controlsMargo R Genderson, Dwight Dickinson, Catherine M Diaz-Asper, et al.Biological Psychiatry|July 4, 2008
Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype?Alan E Ceaser, Terry E Goldberg, Michael F Egan, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 8, 2008
Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNPLeah J Sartorius, Daniel R Weinberger, Thomas M Hyde, et al.Biorxiv : the Preprint Server for Biology|October 3, 2023
Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal functionLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.Psychiatry Research|June 27, 2006
Regional distribution of measurement error in diffusion tensor imagingStefano Marenco, Robert Rawlings, Gustavo K Rohde, et al.Neuroreport|August 23, 2007
Amygdala activation in affective priming: a magnetoencephalogram studyMaite Garolera, Richard Coppola, Karen E Muñoz, et al.The American Journal of Psychiatry|March 3, 2005
Remission in schizophrenia: proposed criteria and rationale for consensusNancy C Andreasen, William T Carpenter, John M Kane, et al.Nature Neuroscience|November 2, 2022
Analysis of the caudate nucleus transcriptome in individuals with schizophrenia highlights effects of antipsychotics and new risk genesKynon J M Benjamin, Qiang Chen, Andrew E Jaffe, et al.Pageof 57